Recommendations of the Russian League Against Epilepsy (RLAE) on the use of magnetic resonance imaging in the diagnosis of epilepsy

Introduction. The MRI method has revolutionized the diagnosis of epilepsy. However, the widespread adoption of MRI in clinical practice is slowed by an insufficient number of high-field MRI scanners, a shortage of trained specialists, and the lack of standard examination protocols. The aim of this article is to present the Recommendations of the Russian League Against Epilepsy (RLAE) on the use of magnetic resonance imaging in the diagnosis of epilepsy.

Materials and methods. As a structural element of the International League Against Epilepsy (ILAE), the RLAE considers it important to adapt the Protocol developed by ILAE for specialists in Russia and EAEU countries. The working group analyzed and generalized the clinical practice existing in the Russian Federation, the Republic of Kazakhstan, the Republic of Belarus and the Republic of Uzbekistan. These recommendations are intended for doctors in specialized centers of epilepsy surgery, and for doctors in general medical centers. The recommendations are applicable primarily to adult patients, but the general principles are relevant to children as well.

Results. In all patients with convulsive seizures shortly after the first seizure, or patients diagnosed with epilepsy who have an unexplained increase in the frequency of seizures, rapid decrease in cognitive functions or the appearance / worsening of neuropsychiatric symptoms, the RLAE recommends using a unified MR protocol for the neuroimaging of structural sequences in epilepsy with three-dimensional pulse sequences T1 and T2 FLAIR with isotropic voxel 1 × 1 × 1 mm3 and two-dimensional T2- weighted pulse sequences with a pixel size of 1 × 1 mm2 or less. The MRI examination should be combined with EEG or EEG-video monitoring. Using this protocol allows one to set a unified standard for examining patients with epilepsy in order to detect (with high sensitivity) brain lesions playing a key role in the occurrence of seizures. Here, all 13 recommendations are presented.

Conclusion. Implementation of these recommendations in clinical practice will improve the access to high-tech medical care and optimize health care costs. 

1. Fountain N. B., Van Ness P. C., Swain-Eng R. et al. Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology. 2011; 76: 94.

2. Epilepsy. WHO Bulletin. 17.02.2019. [Electronic resource] URL: https://www.who.int/ru/news-room/fact-sheets/detail/epilepsy. Accessed: 22.06.2019.

3. Pyadushkina E.A., Frolov M.Y. Slinical and economic evaluation of lacosamide in patients with partial epilepsy. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2016; 9 (3): 38-47. (In Russ.) https://doi.org/10.17749/2070-4909.2016.9.3.038-047.

4. Avakyan G.N. Issues of current epileptology. Epilepsia i paroksizmalʹnye sostoania / Epilepsy and Paroxysmal Conditions. 2015; 7 (4): 16-21 (In Russ.).

5. Mazina N.K., Mazin P.V., Kislitsin Y.V., Markova E.M. Pharmacoeconomic evaluation of rufinamide use for the lennox-gastaut syndrome treatment. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2016; 9 (1): 15-22. (In Russ.) https://doi.org/10.17749/2070-4909.2016.9.1.015-022.

6. Mil’chakova L.E. Epidemiology of epilepsy in individual constituent entities of the Russian Federation: epidemiology, clinic, social aspects, possibilities for optimizing pharmacotherapy: author. dis. ... doctors of medical sciences. Moscow. 2008. 32 s. (In Russ.)

7. Epilepsy: a public health imperative. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.

8. Daikhes A.N., Fedyaev D.V. Provision of free medical care in Russia and elsewhere: review of regulatory and legal aspects. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2017; 10 (3): 59-65. (In Russ.) https://doi. org/10.17749/2070-4909.2017.10.3.059-065.

9. Skorinski M., Klements K.M., O’Sillivan A.K. Budget Impact Analysis of Antiepileptic Drugs for Lennox-Gastaut Syndrome. J. Of Managed Care Pharmacy JMCP. 2014; 4 (20): 400-6.

10. Solomatin Y.V., Rubleva Y.V. The selective serotonin reuptake inhibitor (SSRI) as treatment of depression in patients with epilepsy. Epilepsia i paroksizmalʹnye sostoania / Epilepsy and Paroxysmal Conditions. 2016; 8 (3): 11-18. (In Russ.) https://doi.org/10.17749/2077-8333.2016.8.3.011-018.

11. Jette N., Reid A.Y., Wiebe S. Surgical management of epilepsy. CMAJ. 2014; 186 (13): 997-1004.

12. Picot M.C., Jaussent A., Neveu D., Kahane P., Crespel A., Gelisse P. et al. Cost-effectiveness analysis of epilepsy surgery in a controlled cohort of adult patients with intractable partial epilepsy: a 5-year follow-up study. Epilepsia. 2016; 57 (10): 1669-79.

13. Langfi tt J.T., Holloway R.G., McDermott M.P., Messing S., Sarosky K., Berg A.T., et al. Health care costs decline after successful epilepsy surgery. Neurology. 2007; 68 (16): 1290-8.

14. Jetté N., Wiebe S. Health economic analyses of epilepsy surgery. In: Malmgren K, Baxendale S, Cross H, editors. Long-term outcomes of epilepsy surgery in adults and children. Switzerland: Springer International Publishing. 2015; 225-267.

15. Totolyan A.A. Magnetic resonance imaging in assessing structural changes in the brain in patients with localization-related epilepsy, an integrated approach. Luchevaya diagnostika i terapiya. 2013; 4 (4): 42-50 (In Russ.).

16. Totolyan A.A., Trofimova T.N. Algorithms for MRI of the brain in patients with localization-related epilepsy. Luchevaya diagnostika i terapiya. 2014; 3 (5): 43-51 (In Russ.).

17. Bernasconi A., Cendes F., Theodore W.H., Gill R.S., Koepp M.J., Hogan R.E., Jackson G.D., Federico P., Labate A., Vaudano A.E., Blümcke I., Ryvlin P., Bernasconi N. Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia. 2019 Jun; 60 (6): 1054-1068. DOI: 10.1111/epi.15612. Epub 2019 May 28.

18. Epilepsy in adults. Quality standard. NICE. 2013. [Electronic resource] URL: www.nice.org.uk/guidance/qs26 Accessed: 06.07.2019.

19. Anan’eva N.I., Ezhova R.V., Khalikov A.D., Totolyan A.A. Algorithm for MRI research in epilepsy: necessary and sufficient. School V.M. Bekhterev: from the beginnings to the present: materials of the All-Russian Scientific and Practical Conference with international participation dedicated to the 160th birthday of Vladimir Mikhailovich Bekhterev and the 110th anniversary of the St. Petersburg Psychoneurological Research Institute named after V.M. Bekhterev [Electronic resource]. SPb. 2017; 1 el. opt. disk (CD-ROM). ISBN 978-5-905498- 68-8 (In Russ.).

20. Standards for performing magnetic resonance imaging of the brain for the diagnosis of epilepsy. Moscow. 2016; 15 s. (In Russ.).

21. Clinical recommendations for preoperative examination and surgical treatment of patients with pharmacologically resistant forms of epilepsy. Association of Neurosurgeons of Russia. Moscow. 2015; 22 s. (In Russ.).

22. Clinical protocol of epilepsy; epileptic status. Approved by the minutes of the meeting of the Expert Commission on Healthcare Development of the Ministry of Health of the Republic of Kazakhstan No. 23 dated December 12, 2013. (In Russ.).

23. Asilbekov U.E. The algorithm for the diagnosis of convulsive conditions in young children. Neirokhirurgiya i nevrologiya Kazakhstana. 2012; 1 (26): 3-9. (In Russ.).

24. Bondareva I.V., Savinov S.V., Akchurina Ya.E., Mikhailova N.V., Utebekov Zh.E., Sitnikov I.Yu., Sinitsyna T.N., Abedimova R.A. Algorithm for neurophysiological and neurovisual diagnosis of patients with focal form of epilepsy. Neirokhirurgiya i nevrologiya Kazakhstana. 2014; 3 (36): 16-21 (In Russ.).

25. The differential diagnosis of epilepsy and syncope. Minsk. 2013; 7 s. (In Russ.).

26. Serak A.A., Naumenko V.D. Cortical dysplasia as a cause of symptomatic epilepsy in children: MRI diagnostics and clinical features. 70th International Scientific and Practical Conference of Students and Young Scientists “Actual Problems of Modern Medicine and Pharmacy – 2016”. Conference proceedings. Minsk. 2016; 929-934 (In Russ.).

27. Serak A.A. The possibilities of MRI in the diagnosis of morphological changes in the hippocampus associated with the development of medial temporal lobe epilepsy. Smolensk medical almanac. Smolenskii meditsinskii al’manakh. 2017; 1: 321-325 (In Russ.).

28. Ikramov A. I., Aminov Kh. D. The role of diffusion-weighted magnetic resonance imaging in the diagnosis of symptomatic epilepsy against the background of abnormalities in the development of the brain in children. Radiologiya – Praktika. 2015; 6 (54): 35-45 (In Russ.).

29. International League Against Epilepsy. [Electronic resource] URL: https://www.ilae.org. Accessed: 22.06.2019.

30. Avakyan G.N. Key milestones in the development of the International and Russian Leagues Against Epilepsy. Epilepsia i paroksizmalʹnye sostoania / Epilepsy and Paroxysmal Conditions. 2010; 2 (1): 13-24. (In Russ.)

31. Commission on Neuroimaging of the International League Against Epilepsy. Recommendations for neuroimaging of patients with epilepsy. Epilepsia. 1997; 38: 1255-6.

32. Commission on Neuroimaging of the International League Against Epilepsy. Guidelines for neuroimaging evaluation of patients with uncontrolled epilepsy considered for surgery. Epilepsia. 1998; 39: 1375-6.

33. Neuroimaging Subcommision of the International League Against Epilepsy. Commission on Diagnostic Strategies: recommendations for functional neuroimaging of persons with epilepsy. Epilepsia. 2000; 41: 1350-6.

34. Gaillard W.D., Chiron C., Cross J.H., et al. Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia. 2009; 50: 2147-53.

35. Wilmshurst J.M., Gaillard W.D., Vinayan K.P., et al. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia. 2015; 56: 1185-97.

36. Adler S., Hong S.J., Liu M., et al. Topographic principles of cortical fluid-attenuated inversion recovery signal in temporal lobe epilepsy. Epilepsia. 2018; 59: 627-35.

37. MRI (magnetic resonance imaging), nuclear magnetic resonance imaging (NMR) or magnetic resonance imaging (MRI) [Electronic resource]. URL: https://www.nazdor.ru/topics/improvement/devices/current/463100/. Accessed: 05.07.2019.

38. Krumholz A., Wiebe S., Gronseth G.S., et al. Evidence-based guideline: management of an unprovoked first seizure in adults: report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2015; 84: 1705-13.

39. Hakami T., McIntosh A., Todaro M., et al. MRI-identified pathology in adults with new-onset seizures. Neurology. 2013; 81: 920-7.

40. Semah F, Picot MC, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998; 51: 1256-62.

41. World Health Organization. Global maps for diagnostic imaging. 2014. [Electronic resource] URL: https://www.who.int/diagnostic_imaging/collaboration/global_collab_maps/en/. Accessed: 09.07.2019.

42. Harden C.L., Huff J.S., Schwartz T.H., et al. Reassessment: neuroimaging in the emergency patient presenting with seizure (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2007; 69: 1772-80.

43. Middlebrooks E.H., Ver Hoef L., Szaflarski J.P. Neuroimaging in epilepsy. Curr Neurol Neurosci Rep. 2017; 17: 32.

44. Scheffer I.E., Berkovic S., Capovilla G., et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58: 512-21.

45. Wiebe S., Jette N. Pharmacoresistance and the role of surgery in difficult to treat epilepsy. Nat Rev Neurol. 2012; 8: 669-77.

46. Berg A.T., Berkovic S.F., Brodie M.J., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010; 51: 676-85.

47. Blumcke I., Spreafico R., Haaker G., et al. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med. 2017; 377: 1648-56.

48. Eltze C.M., Chong W.K., Bhate S., Harding B., Neville B.G., Cross J.H. Taylor-type focal cortical dysplasia in infants: some MRI lesions almost disappear with maturation of myelination. Epilepsia. 2005; 46: 1988-92.

49. Kwan P., Arzimanoglou A., Berg A.T., et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010; 51: 1069-77.

50. Engel J Jr. What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg Lecture. Neurology. 2016; 87: 2483-9.

51. Labate A., Aguglia U., Tripepi G., et al. Long-term outcome of mild mesial temporal lobe epilepsy: a prospective longitudinal cohort study. Neurology. 2016; 86: 1904-10.

52. Tellez-Zenteno J.F., Hernandez Ronquillo L., Moien-Afshari F., Wiebe S. Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis. Epilepsy Res. 2010; 89: 310-8.

53. Simasathien T., Vadera S., Najm I., Gupta A., Bingaman W., Jehi L. Improved outcomes with earlier surgery for intractable frontal lobe epilepsy. Ann Neurol. 2013; 73: 646-54.

54. Federal law of November 21, 2011 N 323-ФЗ “On the basics of protecting the health of citizens in the Russian Federation”. Quoted from the Guarantor Base. [Electronic resource] URL: https://base.garant.ru/57499516/. Accessed: 02.07.2019. (in Russ).

55. Letter of the Ministry of Health of Russia dated April 30, 2013 No. 13-2 / 10 / 2-3113 “On the application of standards and procedures for the provision of medical care.” [Electronic resource] URL: https://www.rosminzdrav.ru/documents/5521-pismo-. Accessed: 02.07.2019. (in Russ).

56. Cloppenborg T., May T.W., Blumcke I., et al. Trends in epilepsy surgery: stable surgical numbers despite increasing presurgical volumes. J Neurol Neurosurg Psychiatry. 2016; 87: 1322-9.

57. Burneo J.G., Shariff S.Z., Liu K., Leonard S., Saposnik G., Garg A.X. Disparities in surgery among patients with intractable epilepsy in a universal health system. Neurology. 2016; 86: 72-78.

58. Roberts J.I., Hrazdil C., Wiebe S., et al. Neurologists’ knowledge of and attitudes toward epilepsy surgery: a national survey. Neurology. 2015; 84: 159-66.

59. Jehi L., Mathern G.W. Who’s responsible to refer for epilepsy surgery? We all are! Neurology. 2015; 84: 112-3.

60. Wiebe S. Burden of intractable epilepsy. Adv Neurol. 2006; 97: 1-4.

61. Avakyan G.N., Blinov D.V., Lebedeva A.V., Burd S.G., Avakyan G.G. ILAE classification of the epilepsies: the 2017 revision and update. Epilepsia i paroksizmalʹnye sostoania / Epilepsy and Paroxysmal Conditions. 2017; 9 (1): 6-25. (In Russ.) DOI: https://doi.org/10.17749/2077-8333.2017.9.1.006-025.

62. Nickels K.C., Zaccariello M.J., Hamiwka L.D., Wirrell E.C. Cognitive and neurodevelopmental comorbidities in paediatric epilepsy. Nat Rev Neurol. 2016; 12: 465-76.

63. Von Oertzen J., Urbach H., Jungbluth S. et al. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry. 2002; 73: 643-7.

64. Bernhardt B.C., Kim H., Bernasconi N. Patterns of subregional mesiotemporal disease progression in temporal lobe epilepsy. Neurology. 2013; 81: 1840-7.

65. Caciagli L., Bernasconi A., Wiebe S., Koepp M.J., Bernasconi N., Bernhardt B.C. A meta-analysis on progressive atrophy in intractable temporal lobe epilepsy: time is brain? Neurology. 2017; 89: 506-16.

66. Bernhardt B.C., Worsley K.J., Kim H., Evans A.C., Bernasconi A., Bernasconi N. Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy. Neurology. 2009; 72: 1747-54.

67. Bernhardt B.C., Bernasconi N., Concha L., Bernasconi A. Cortical thickness analysis in temporal lobe epilepsy: reproducibility and relation to outcome. Neurology. 2010; 74: 1776-84.

68. Bernasconi A, Bernasconi N, Bernhardt BC, Schrader D. Advances in MRI for ‘cryptogenic’ epilepsies. Nat Rev Neurol. 2011; 7: 99-108.

69. Winston G.P., Micallef C., Kendell B.E., et al. The value of repeat neuroimaging for epilepsy at a tertiary referral centre: 16 years of experience. Epilepsy Res. 2013; 105: 349-55.

70. Kokkinos V., Kallifatidis A., Kapsalaki E.Z., Papanikolaou N., Garganis K. Thin isotropic FLAIR MR images at 1.5T increase the yield of focal cortical dysplasia transmantle sign detection in frontal lobe epilepsy. Epilepsy Res. 2017; 132: 1-7.

71. Knake S., Triantafyllou C., Wald L.L., et al. 3T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study. Neurology. 2005; 65: 1026-31.

72. Mellerio C., Labeyrie M.A., Chassoux F., et al. 3T MRI improves the detection of transmantle sign in type 2 focal cortical dysplasia. Epilepsia. 2014; 55: 117-22.

73. Hong S.J., Kim H., Schrader D., Bernasconi N., Bernhardt B.C., Bernasconi A. Automated detection of cortical dysplasia type II in MRI-negative epilepsy. Neurology. 2014; 83: 48-55.

74. Bernasconi N., Bernasconi A. Epilepsy: imaging the epileptic brain – time for new standards. Nat Rev Neurol. 2014; 10: 133-4.

75. Blumcke I., Thom M., Aronica E., et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a task force report from the ILAE Commission on Diagnostic Methods. Epilepsia. 2013; 54: 1315-29.

76. Thom M. Review: Hippocampal sclerosis in epilepsy: a neuropathology review. Neuropathol Appl Neurobiol. 2014; 40: 520-43.

77. Kulaga-Yoskovitz J., Bernhardt B.C., Hong S.J., et al. Multi-contrast submillimetric 3 tesla hippocampal subfield segmentation protocol and dataset. Sci Data. 2015; 2: 150059.

78. Bernasconi N., Kinay D., Andermann F., Antel S., Bernasconi A. Analysis of shape and positioning of the hippocampal formation: an MRI study in patients with partial epilepsy and healthy controls. Brain. 2005; 128: 2442-52.

79. Tsai M.H., Vaughan D.N., Perchyonok Y., et al. Hippocampal malrotation is an anatomic variant and has no clinical significance in MRI-negative temporal lobe epilepsy. Epilepsia. 2016; 57: 1719-28.

80. Abou-Hamden A., Lau M., Fabinyi G., et al. Small temporal pole encephaloceles: a treatable cause of “lesion negative” temporal lobe epilepsy. Epilepsia. 2010; 51: 2199-202.

81. Toledano R., Jimenez-Huete A., Campo P., et al. Small temporal pole encephalocele: a hidden cause of “normal” MRI temporal lobe epilepsy. Epilepsia. 2016; 57: 841-51.

82. Saavalainen T., Jutila L., Mervaala E., Kälviäinen R., Vanninen R, Immonen A. Temporal anteroinferior encephalocele: an underrecognized etiology of temporal lobe epilepsy? Neurology. 2015; 85: 1467-74.

83. Pillay N., Fabinyi G.C., Myles T.S., Fitt G.J., Berkovic S.F., Jackson G.D. Parahippocampal epilepsy with subtle dysplasia: a cause of “imaging negative” partial epilepsy. Epilepsia. 2009; 50: 2611-8.

84. Thompson S.A., Kalamangalam G.P., Tandon N. Intracranial evaluation and laser ablation for epilepsy with periventricular nodular heterotopia. Seizure. 2016; 41: 211-6.

85. Blumcke I., Thom M., Aronica E., et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification pro-posed by an ad hoc task force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011; 52: 158-74.

86. Besson P., Andermann F., Dubeau F., Bernasconi A. Small focal cortical dysplasia lesions are located at the bottom of a deep sulcus. Brain. 2008; 131: 3246-55.

87. So E.L., Lee R.W. Epilepsy surgery in MRI-negative epilepsies. Curr Opin Neurol. 2014; 27: 206-12.

88. Bernasconi A., Bernasconi N. Unveiling epileptogenic lesions: the contribution of image processing. Epilepsia. 2011; 52 (Suppl 4): 20-4.

89. Martin P., Bender B., Focke N.K. Post-processing of structural MRI for individualized diagnostics. Quant Imaging Med Surg. 2015; 5: 188-203.

90. Kini L.G., Gee J.C., Litt B. Computational analysis in epilepsy neuroimaging: a survey of features and methods. Neuroimage Clin. 2016; 11: 515-29.

91. Gaillard W.D., Cross J.H., Duncan J.S., Stefan H., Theodore W.H. Task Force on Practice Parameter Imaging Guidelines for International League Against Epilepsy, Commission for Diagnostics. Epilepsy imaging study guideline criteria: commentary on diagnostic testing study guidelines and practice parameters. Epilepsia. 2011; 52: 1750-6.

92. Bernasconi A., Antel S.B., Collins D.L., et al. Texture analysis and morphological processing of magnetic resonance imaging assist detection of focal cortical dysplasia in extra-temporal partial epilepsy. Ann Neurol. 2001; 49: 770-5.

93. Colliot O., Bernasconi N., Khalili N., Antel S.B., Naessens V., Bernasconi A. Individual voxel-based analysis of gray matter in focal cortical dysplasia. Neuroimage. 2006; 29: 162-71.

94. Wagner J., Weber B., Urbach H., Elger C.E., Huppertz H.J. Morphometric MRI analysis improves detection of focal cortical dysplasia type II. Brain. 2011; 134: 2844-54.

95. Huppertz H.J., Kurthen M., Kassubek J. Voxel-based 3D MRI analysis for the detection of epileptogenic lesions at single subject level. Epilepsia. 2009; 50: 155-6.

96. Goubran M., Bernhardt B.C., Cantor-Rivera D., et al. In vivo MRI signatures of hippocampal subfield pathology in intractable epilepsy. Hum Brain Mapp. 2016; 37: 1103-19.

97. Aghakhani Y., Liu X., Jette N., Wiebe S. Epilepsy surgery in patients with bilateral temporal lobe seizures: a systematic review. Epilepsia. 2014; 55: 1892-901.

98. Duncan J.S., Winston G.P., Koepp M.J., Ourselin S. Brain imaging in the assessment for epilepsy surgery. Lancet Neurol. 2016; 15: 420-33.

99. Sone D., Sato N., Maikusa N., et al. Automated subfield volumetric analysis of hippocampus in temporal lobe epilepsy using high-resolution T2-weighed MR imaging. Neuroimage Clin. 2016; 12: 57-64.

100. Hosseini M.P., Nazem-Zadeh M.R., Pompili D., et al. Comparative performance evaluation of automated segmentation methods of hippocampus from magnetic resonance images of temporal lobe epilepsy patients. Med Phys. 2016; 43: 538.

101. Kim H., Mansi T., Bernasconi N., Bernasconi A. Surface-based multi-template automated hippocampal segmentation: application to temporal lobe epilepsy. Med Image Anal. 2012; 16: 1445-55.

102. Caldairou B., Bernhardt B.C., Kulaga-Yoskovitz J., Kim H., Bernasconi A., Bernasconi N. A Surface Patch-Based Segmentation Method for Hippocampal Subfields. Cham, Switzerland: Springer International Publishing; 2016: 379-87.

103. Farid N, Girard HM, Kemmotsu N, et al. Temporal lobe epilepsy: quantitative MR volumetry in detection of hippocampal atrophy. Radiology. 2012; 264: 542-50.

104. Kim H., Bernhardt B.C., Kulaga-Yoskovitz J., Bernasconi A., Bernasconi N. Multivariate hippocampal subfield analysis of local MRI intensity and volume: application to temporal lobe epilepsy. Med Image Comput Comput Assist Interv. 2014; 17: 170-8.

105. Bernhardt B.C., Bernasconi A., Liu M., et al. The spectrum of structural and functional imaging abnormalities in temporal lobe epilepsy. Ann Neurol. 2016; 80: 142-53.

106. Jackson G.D., Kuzniecky R.I., Cascino G.D. Hippocampal sclerosis without detectable hippocampal atrophy. Neurology. 1994; 44: 42-6.

107. Kosior R.K., Lauzon M.L., Federico P., Frayne R. Algebraic T2 estimation improves detection of right temporal lobe epilepsy by MR T2 relaxometry. Neuroimage. 2011; 58: 189-97.

108. Peixoto-Santos J.E., Kandratavicius L., Velasco T.R., et al. Individual hippocampal subfield assessment indicates that matrix macromolecules and gliosis are key elements for the increased T2 relaxation time seen in temporal lobe epilepsy. Epilepsia. 2017; 58: 149-59.

109. Bernasconi A., Bernasconi N., Caramanos Z., et al. T2 relaxometry can lateralize mesial temporal lobe epilepsy in patients with nor-mal MRI. Neuroimage. 2000; 12: 739-46.

110. Winston G.P., Vos S.B., Burdett J.L., Cardoso M.J., Ourselin S., Duncan J.S. Automated T2 relaxometry of the hippocampus for temporal lobe epilepsy. Epilepsia. 2017; 58: 1645-52.

111. Hong S.-J., Bernhardt B.C., Caldairou B., et al. Multimodal MRI profiling of focal cortical dysplasia type II. Neurology. 2017; 88: 734-42.

112. Gill R.S., Hong S.J., Fadaie F., et al. Automated detection of epileptogenic cortical malformations using multimodal MRI. In: Cardoso M.J., Arbel T., Carneiro G., et al, eds. Deep Learning in Medical Image Analysis and Multimodal Learning for Clinical Decision Support: Third International Workshop, DLMIA 2017, and 7th International Workshop, ML-CDS 2017, Held in Conjunction with MICCAI 2017, Québec City, QC, Canada, September 14, Proceedings. Cham, Switzerland: Springer International Publishing. 2017; 349-56.

113. Adler S., Wagstyl K., Gunny R., et al. Novel surface features for automated detection of focal cortical dysplasias in paediatric epilepsy. Neuroimage Clin. 2017; 14: 18-27.